Back HCV Prevention

IHRC 2015: Retreat of International Donors, National Government Neglect Threaten Harm Reduction Services

The availability of needle and syringe programs, opioid substitution therapy, and other harm reduction services for people who inject drugs is getting even worse in many parts of the world, due to shifting priorities among international donors and a refusal by many national governments to adequately respond to the health needs of their citizens who use drugs, according to delegates at the 24th International Harm Reduction Conference, being held this week in Kuala Lumpur, Malaysia. UNAIDS estimate that US$2.3 billion is needed each year for a core package of HIV prevention, treatment, and care for people who inject drugs -- but just 7% of this is currently provided.

alt

Read more:

Coverage of the 2015 International Harm Reduction Conference

Coverage of the 24th International Harm Reduction Conference, October 18-22, 2015, in Kuala Lumpur, Malaysia. 

Conference highlights include needle exchange and opioid substitution therapy, programs for people who inject drugs, and international drug policy reform.

Full listing of coverage

IHRC 2015 website

10/21/15

 

alt

Sexual Transmission of HCV Is Increasing Among Gay and Bi Men with HIV

Sexual transmission of hepatitis C virus (HCV) is occurring among HIV-positive men who have sex with men, associated with receptive anal sex and non-injection drug use, and a small subset of men may be prone to recurrent infection after being cured of hepatitis C, according to a meta-analysis reported in the August 7 online edition of AIDS.

alt

Read more:

IHRC 2015: Opioid Substitution Therapy, Especially with Needle Exchange, Reduces Hepatitis C Transmission

A pooled analysis of 25 studies has for the first time shown good evidence that methadone and other forms of opioid substitution therapy substantially reduce new hepatitis C virus (HCV) infections, according to a report presented today at the 24th International Harm Reduction Conference in Kuala Lumpur, Malaysia. Previously, this had been clearly demonstrated for HIV, but not hepatitis C.alt

Read more:

IAS 2015: PrEP and the Risk of Hepatitis C Virus Infection [VIDEO]

 Are gay and bisexual men who take Truvada for HIV pre-exposure prophylaxis (PrEP) at greater risk for sexually transmitted hepatitis C virus (HCV) infection? Experts discussed this issue and others at a media briefing on HIV and hepatitis coinfection at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention last month in Vancouver.

alt

Read more: